Here is some additional commentary on this from "In The Pipeline": https://blogs.sciencemag.org/pipeline/a ... ent-298184
In The Pipeline is a blog I read daily written by someone engaged in medicinal chemistry discovery. Someone that is doing the same sort of Job I used to do. I commented on that post about my concern that in practice it might be difficult to see practical application of the use of mannose unless the manufactures retool so as not to make up the common chemotherapy agents as IV solutions in D5W (Dextrose). Which is my belief that it might rescue the tumors from this Mannose effect. Individual research pharmacies at some NCI cancer centers might undertake reformulating these agents themselves, but most infusion centers probably would continue to buy their normal supplies.
I remember not long ago a patient pointed out she had difficulty getting her oncologist to not use Dextrose solutions for her as she was having problems adjusting her blood sugar being diabetic. Also excessive use of Insulin might drive some tumor types. PI3K inhibitors in cancer therapy have been a mixed bag in the clinic because their down steam effects it turns out muck around with insulin signaling. Sometime if I can relocate the paper about this I will post more information.
This mannose discovery could very well be a great leap forward for some, but its not going to happen over night. Its going to require some clinical trial work to determine how much mannose to use in people and when is the optimal time to use before the FOLFOX infusion. Also we need to understand if the use of D5W in the Infusion rescues the tumor cells from the mannose treatment and should we instead formulate the infusion solutions with Mannose.
If any of you decide to try this. You should let your oncologist know. And also try to get them to use a saline solution instead of Dextrose if possible in the IV infusions. Additionally - did you know that 5-FU is given as an Alkaline solution of between pH 8.6 and 9.4 adjusted that way with sodium hydroxide? I just found that out today. Never knew that before.
DW 53 dx Jun 2013
CT mets Liver Spleen lung. IVb CEA~110
Jul 2013 Sig Resct
8/13 FolFox,Avastin 12Tx mild sfx, Ongoing 5-FU Avastin every 3 wks.
CEA: good marker
7/7/14 CT Can't see the spleen Mets.
8/16/15 CEA Up, CT new abdominal mets. Iri, 5-FU, Avastin every 2 wks.
1/16 Iri, Erbitux and likely Avastin (Trial) CEA going >.
1/17 CEA up again dropped from Trial, Mets growth 4-6 mm in abdomen
5/2/17 Failed second trial, Hospitalized 15 days 5/11. Home Hospice 5/26, at peace 6/4/2017